Point-of-care testing for HBV using Abbott DETERMINE™ Surface Antigen 2 test

Current Status
Not Enrolled
Price
Free
Get Started

Course Overview

Point-of-care tests provide an opportunity for providing testing to people who may not otherwise seek testing from medical settings and can enhance linkage to care. This online learning module outlines the key processes involved in point of care testing of Hepatitis B using using the Abbott DETERMINE™ Surface Antigen 2 test and will take approximately 15 mins to complete.

Target audience: This program is designed for healthcare workers who will perform, or supervise the performance of, Hepatitis C, Hepatitis B, or HIV testing using these devices.

Prerequisite learning: Users must first complete the Infection Control for point-of-care testing module in order to access this course

Last Updated: 9 September 2024

For any issues please contact: [email protected]

This activity was developed, supported and funded by the National Australian Hepatitis C Point-of-Care Testing Program through a collaboration between the Kirby Institute at UNSW Sydney, the International Centre for Point-of-Care Testing at Flinders University, St. Vincent’s Centre for Applied Medical Research and ASHM Health.

Note: The BIOLINE™ HCV Antibody Test and Hepatitis B DETERMINE™ Surface Antigen 2 test are not yet approved by the Therapeutics Goods Administration and can only be used as part of research studies.

Scroll to Top